Lab Manager | Run Your Lab Like a Business
Clearing the Path

Clearing the Path

Smoothing the route to market for your biologics by avoiding HCP delays


Cytiva is a 3.3 billion USD global life sciences leader with nearly 7,000 employees across 40 sites dedicated to advancing and accelerating therapeutics. As a trusted partner to customers that...

ViewFull Profile.
Learn about ourEditorial Policies.

The stakes are high in biologics development, especially in host cell protein (HCP) analysis. Get it wrong and it could delay your development cycle. HCPs are complex. Scientists use a variety of biological expression systems to produce pharmaceutical drugs—systems based around bacteria, yeast, mammalian cells, and plant cells—and each system has a unique HCP profile. See how optimizing your HCP assays can smooth your route to market.

Download this white paper to learn how to optimize host cell protein assays, courtesy of Cytiva.